Vimarsana
Biggest News Aggregation in the World

Page 35 - Repurchase Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Repurchase Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Repurchase Program Today - Breaking & Trending Today

Olin Announces Second Quarter 2022 Results and $2 Billion Share Repurchase Program - Vimarsana News

Olin Announces Second Quarter 2022 Results and $2 Billion Share Repurchase Program

Highlights Second quarter 2022 net income of $422.1 million, or $2.76 per diluted shareRecord quarterly adjusted EBITDA of $727.3 millionShare repurchases of $426.5 million in second quarter...

UNIVERSAL HEALTH SERVICES, INC. REPORTS 2022 SECOND QUARTER FINANCIAL RESULTS - Vimarsana News

UNIVERSAL HEALTH SERVICES, INC. REPORTS 2022 SECOND QUARTER FINANCIAL RESULTS

/PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $164.1 million, or $2.20 per...

Elevance Health Reports Second Quarter 2022 Results, Raises Full Year Outlook - Vimarsana News

Elevance Health Reports Second Quarter 2022 Results, Raises Full Year Outlook

20.07.2022 - Elevance Health, Inc. (NYSE: ELV) reported second quarter 2022 results reflecting strong financial performance, including double-digit growth in revenue, operating earnings, and adjusted earnings per share. 'The disciplined execution of our ...

Flora Growth Stock Remains Undervalued (NASDAQ:FLGC) - Vimarsana News

Flora Growth Stock Remains Undervalued (NASDAQ:FLGC)

Flora shares have slid alongside the broader market. Read more to find out why I believe FLGC stock is still undervalued.

Adagene Announces Authorization of Share Repurchase Program up to US$10 Million - Vimarsana News

Adagene Announces Authorization of Share Repurchase Program up to US$10 Million

Adagene Announces Authorization of Share Repurchase Program up to US$10 Million GlobeNewswire June 29, 2022 SAN DIEGO and SUZHOU, China, June 29, 2022 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that its board of directors has authorized a...